长期护理机构中老年人中药物使用和跌倒风险:一个横截面分析
N Ebrahim1, J Ras1, R November1
1Department of Sport, Recreation and Exercise Science, Faculty of Community and Health Sciences, University of the Western Cape, Robert Sobukwe Rd, Bellville, Cape Town 7535, South Africa.
South African journal of sports medicine
|September 17, 2025
概括
老年人的跌倒是一个重大问题. 这项研究发现,抗抑郁药和抗糖尿病药与居住在护理设施中的老年人中跌倒风险增加有关.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 老年人中跌倒对他们的生活质量和安全构成重大威胁.
- 药物使用是跌倒风险的公认因素,但特定的药物关联需要进一步调查.
- 这项研究解决了在护理机构内与老年人群中跌倒相关的药物识别的关键需求.
研究的目的:
- 调查特定药物使用与长期护理 (LTC) 设施中老年居民中跌倒的发生率之间的直接关系.
- 确定可能会增加这一人口群体中跌倒风险的制药剂.
- 通过强调与药物相关的风险,为防摔策略提供信息.
主要方法:
- 采用横截面研究设计,涉及60岁及以上的男性和女性参与者.
- 258名参与者从南非开普敦的多个LTC设施中被招募,使用方便抽样.
- 斯皮尔曼的等级相关系数被用来分析跌倒,跌倒风险因素和药物使用之间的关联.
主要成果:
- 大多数参与者 (81%) 被评估为低风险的跌倒.
- 抗抑郁药物治疗与跌倒风险增加显著相关 (OR=2.083).
- 抗糖尿病药物也与较高的跌倒风险相关 (OR=2.070).
结论:
- 抗抑郁药物和抗糖尿病药物的使用与老年人中跌倒风险增加之间存在显著联系.
- 这些发现强调了强有力的药物管理和为老年居民量身定制的防摔计划的重要性.
- 医疗保健提供者应该对这些药物进行彻底的风险评估,并在为老年人开处方时考虑替代品.
相关概念视频
01:15Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197